• Carbohydrate-Decorated Nanoparticles for Macrophage-Targeted

  2026-05-09

  This study introduces biodegradable nanoparticles decorated with specific carbohydrates to enhance the targeted delivery of mRNA and plasmid DNA to macrophages. The approach demonstrates improved uptake, high encapsulation efficiency, and low cytotoxicity, offering a foundation for precise gene therapy targeting macrophage-driven diseases.

• Losartan in Hypertension Research: Applied Protocols & Insig

  2026-05-08

  Losartan unlocks new precision in hypertension and vascular biology research by enabling reproducible inhibition of angiotensin II signaling pathways. This guide delivers actionable workflows, troubleshooting strategies, and evidence-based parameterization, empowering investigators to maximize both in vitro and in vivo study outcomes.

• Moxidectin: Macrocyclic Lactone Anthelmintic in Antifungal S

  2026-05-08

  Moxidectin, a macrocyclic lactone anthelmintic, now demonstrates powerful synergy with polyene antifungals for combating Candida albicans in translational models. Explore advanced workflows, protocol optimizations, and troubleshooting insights that leverage APExBIO's high-purity moxidectin for both veterinary antiparasitic and emerging antifungal research.

• 4-Phenylbutyric Acid (4-PBA): Reliable Solutions for ER Stre

  2026-05-07

  This article offers scenario-driven, evidence-based guidance for using 4-Phenylbutyric acid (SKU C6831) in cell viability and ER stress research. Through real-world laboratory scenarios, we demonstrate how APExBIO’s high-purity 4-PBA enables reproducible, sensitive, and workflow-compatible solutions for apoptosis, autophagy, and cytotoxicity assays.

• In Vitro Activity of Sisomicin Versus Tobramycin and Gentami

  2026-05-07

  This article examines Stewart and Bodey's investigation of sisomicin, a new aminoglycoside antibiotic, comparing its in vitro efficacy against clinical bacterial isolates with that of established agents such as tobramycin and gentamicin. The study's robust comparative approach provides critical insights for antibiotic resistance research, informing experimental assay design and antimicrobial stewardship.

• Haloprogin (SKU BA1790): Reliable Antifungal Solutions for L

  2026-05-06

  This article provides scenario-driven, evidence-based guidance for researchers evaluating Haloprogin (SKU BA1790) in cell viability and antimicrobial assays. It addresses protocol optimization, data interpretation, and supplier selection, offering practical insights for reproducible antimicrobial research with Haloprogin.

• Tetraethylammonium Chloride: Applied K+ Channel Blockade Wor

  2026-05-06

  Tetraethylammonium chloride (TEAC) from APExBIO redefines potassium channel research with robust blockade, dual-site versatility, and application flexibility. This guide unpacks real experimental workflows, advanced assay design, and troubleshooting strategies to accelerate breakthroughs in vascular, metabolic, and neurophysiological models.

• Haloprogin in Precision Antimicrobial Assays: Protocol and E

  2026-05-05

  Explore Haloprogin’s unique role as a broad-spectrum antimicrobial in precision research. This in-depth analysis details optimized protocols, evidence-based MIC values, and practical insights from seminal studies.

• Dextran Sulfate Sodium Salt (MW 35000-45000): Beyond Colitis

  2026-05-05

  Discover how Dextran sulfate sodium salt (MW 35000-45000) enables advanced, mechanistically informed mouse models of intestinal inflammation. This article explores the translational impact of epithelial repair pathways and practical protocol insights for ulcerative colitis research.

• EdU Flow Cytometry Assay Kits (Cy5): Mechanism, Evidence & U

  2026-05-04

  EdU Flow Cytometry Assay Kits (Cy5) enable precise, no-denaturation DNA synthesis detection in flow cytometry using copper-catalyzed azide-alkyne cycloaddition (CuAAC). These kits offer high sensitivity and specificity for S-phase cell proliferation analysis, outperforming BrdU-based assays.

• Epoxomicin: Mechanistic Powerhouse for Translational Discove

  2026-05-04

  This thought-leadership article explores the mechanistic nuances and translational promise of Epoxomicin as a selective, irreversible proteasome inhibitor. We bridge foundational biology with actionable strategies for researchers targeting the ubiquitin-proteasome pathway in inflammation and neurodegeneration models, integrating recent viral immunology breakthroughs and competitive landscape insights.

• Dextran Sulfate Sodium Salt: Optimizing DSS Colitis Models

  2026-05-03

  Dextran sulfate sodium salt (MW 35000-45000) empowers reproducible, mechanistically relevant models of intestinal inflammation, enabling advanced study of epithelial repair and drug evaluation. Discover how APExBIO’s DSS underpins cutting-edge ulcerative colitis research, with actionable workflow improvements and troubleshooting tips for robust, translational results.

• Tobramycin: Applied Workflows for Antibiotic Resistance Rese

  2026-05-02

  Tobramycin, a high-purity aminoglycoside antibiotic from APExBIO, is a gold standard in experimental workflows tackling Gram-negative bacterial infections and resistance mechanisms. This article bridges bench protocols and troubleshooting expertise, guiding researchers to optimize tobramycin’s use in microbiology and antibiotic resistance research.

• HIF1α/PRDX1 Axis in Pulmonary Hypertension: Mitochondrial Dy

  2026-05-01

  This study reveals that the HIF1α-driven upregulation of PRDX1 orchestrates pulmonary vascular remodeling in hypoxic conditions by mediating DRP1 deSUMOylation and promoting mitochondrial fragmentation. These findings establish a mechanistic link between hypoxia, endothelial dysfunction, and maladaptive vascular changes, identifying PRDX1 as a potential therapeutic target in pulmonary hypertension.

• Frizzled5 as a Cholesterol Sensor in Wnt/β-Catenin-Driven Ca

  2026-05-01

  This study reveals a unique mechanism by which Frizzled5 directly binds cholesterol, linking aberrant cholesterol metabolism to Wnt/β-catenin signaling in pancreatic cancer. The findings uncover a novel axis for tumor growth regulation and suggest new research avenues for targeted therapies.

15947 records 1/1064 page Next 12345 下5页 Last page